Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific Group to Attend the 4th Annual International Umbilical Cord Blood Transplantation Symposium in Los Angeles.


SAN DIEGO -- Bio-Matrix Scientific Group, Inc. (Pink Sheets:BMXP BMXP Boston Metropolitan Exchange Point ), a biotechnology company focused on stem cell cryogenics cryogenics: see low-temperature physics.
cryogenics

Study and use of low-temperature phenomena. The cryogenic temperature range is from −238°F (−150°C) to absolute zero. At low temperatures, matter has unusual properties.
 and disposable stem cell / tissue transfer instruments, (http://www.bmxgonline.com), announced today that Dr. Geoffrey O'Neill, President of Bio-Matrix, will attend the 4th Annual International Umbilical Cord Blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy.  Transplantation Symposium in Los Angeles, May 19-20, 2006. Dr. O'Neill is widely recognized for his extensive research in stem cell and transplant applications.

The 31 member faculty for the Symposium includes leaders of major transplant centers in the United States, France, Japan, Spain and Taiwan. Attendees will include visitors from Japan, New Zealand, Australia, Singapore, France, the UK, Israel, Mexico, Columbia, Cyprus, Switzerland, India, Sweden, Italy, Taiwan, Kuwait, Saudi Arabia, the UAE (Uninterruptible Application Error) The name given to a crash in Windows 3.0. In subsequent versions of Windows, a crash was called a "General Protection Fault," "Application Error" or "Illegal Operation." See crash in Windows and abend. , Greece, Canada, Chile, Korea and from around the United States.

Topics for review include transplantation of adults, infectious complications and immune reconstitution approaches to improve the efficacy of cord blood transplants, quality issues in cord blood banking, transplantation of children, regenerative medicine and accreditation issues.

At the conclusion of the Symposium, attendees will possess the ability to:

--Describe patient selection and outcomes for pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 and adult patients undergoing unrelated cord blood transplantation versus transplantation from other stem cell sources.

--Identify the factors that affect outcomes, including cord blood unit selection and HLA matching criteria, conditioning regimens, and supportive care strategies.

--Discuss the potential role of cord blood transplantation based on new research developments. Discuss critical issues in cord blood banking.

This press release is available on the company's official online Investor Relations HUB at http://www.agoracom.com/IR/Bio-Matrix for investor questions, answers and monitored commentary. Alternatively, investors are able to e-mail all questions and correspondence to BMXP@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are Cord Blood America (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CBAI CBAI The Community Bankers Association of Illinois
CBAI Contract Bridge Association of Ireland (UK) 
), StemCells Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:STEM) and Regeneration Technologies (OTCBB:RTIX).

More information will be available shortly on the Company's website: www.BMXGonline.com

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 10, 2006
Words:467
Previous Article:Avantogen and Hawaii Biotech Combine Vaccine Businesses; World-Class Vaccine Developer is Created to Accelerate Pandemic Influenza, West Nile and...
Next Article:UTEK Completes Technology Transfer to Industrial Biotechnology Corporation; Worldwide Exclusive License for the Use of Nootkatone in Natural Insect...
Topics:



Related Articles
Cord Blood Ads False?
AGOURA HILLS BOY SET FOR TRANSPLANT; CHILD TO GET BROTHER'S BLOOD TO FIGHT LEUKEMIA.
UMBILICAL-CORD BLOOD CELLS OFFER NEW HOPE.
LIFEBLOOD BANKING UMBILICAL CORD STEM CELLS FOR TREATMENT OF DISEASES SEEMS LIKE GOOD INSURANCE - BUT DOES THE POLICY REALLY PAY OFF?
Umbilical bounty: cord blood shows value against leukemia.
Stem-cell ethics.
Health sciences.
"Yes" to adult stem cells.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles